Cargando…
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
BACKGROUND: Randomized controlled trials and retrospective studies in ANCA-associated vasculitis (AAV) concurred that rituximab (RTX) is effective to induce and maintain remission. Infections and hypogammaglobulinemia during RTX were usually infrequent and uncomplicated. But in the Tromsø study coho...
Autor principal: | Besada, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702309/ https://www.ncbi.nlm.nih.gov/pubmed/26738559 http://dx.doi.org/10.1186/s12891-015-0860-3 |
Ejemplares similares
-
Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab
por: Besada, Emilio
Publicado: (2016) -
Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
por: Melega, Simone, et al.
Publicado: (2022) -
Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
por: Besada, Emilio, et al.
Publicado: (2015) -
CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patients
por: Besada, Emilio, et al.
Publicado: (2016) -
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)